Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.

Chisesi T, Bellei M, Luminari S, Montanini A, Marcheselli L, Levis A, Gobbi P, Vitolo U, Stelitano C, Pavone V, Merli F, Liberati M, Baldini L, Bordonaro R, Pesce EA, Federico M.

J Clin Oncol. 2011 Nov 10;29(32):4227-33. doi: 10.1200/JCO.2010.30.9799. Epub 2011 Oct 11.

PMID:
21990405
2.

Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Zinzani PL, Martelli M, Poletti V, Vitolo U, Gobbi PG, Chisesi T, Barosi G, Ferreri AJ, Marchetti M, Pimpinelli N, Tura S; Italian Society of Hematology; Italian Society of Experimental Hematology; Italian Group for Bone Marrow Transplantation.

Haematologica. 2008 Sep;93(9):1364-71. doi: 10.3324/haematol.12742. Epub 2008 Jul 4.

3.

Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.

Rigacci L, Vitolo U, Nassi L, Merli F, Gallamini A, Pregno P, Alvarez I, Salvi F, Sancetta R, Castagnoli A, Versari A, Biggi A, Gregianin M, Pelosi E, Chisesi T, Bosi A, Levis A; Intergruppo Italiano Linfomi.

Ann Hematol. 2007 Dec;86(12):897-903. Epub 2007 Aug 16.

PMID:
17701410
4.

High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission.

Majolino I, Ladetto M, Locasciulli A, Drandi D, Benedetti F, Gallamini A, Chisesi T, De Blasio A, Boccadoro M, Tarella C.

Med Oncol. 2006;23(3):359-68.

PMID:
17018893
5.

MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.

Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.

Clin Cancer Res. 2006 Jan 15;12(2):529-35.

6.

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M; Intergruppo Italiano Linfomi.

J Clin Oncol. 2005 Dec 20;23(36):9198-207. Epub 2005 Sep 19.

PMID:
16172458
7.

Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.

Olivieri A, Santini G, Patti C, Chisesi T, De Souza C, Rubagotti A, Aversa S, Billio A, Porcellini A, Candela M, Centurioni R, Congiu AM, Brunori M, Nati S, Spriano M, Vimercati R, Marino G, Contu A, Tedeschi L, Majolino I, Crugnola M, Sertoli MR; NHLCSG.

Ann Oncol. 2005 Dec;16(12):1941-8. Epub 2005 Sep 12.

PMID:
16157621
8.

Meta-analysis to evaluate the role of interferon in follicular lymphoma.

Rohatiner AZ, Gregory WM, Peterson B, Borden E, Solal-Celigny P, Hagenbeek A, Fisher RI, Unterhalt M, Arranz R, Chisesi T, Aviles A, Lister TA.

J Clin Oncol. 2005 Apr 1;23(10):2215-23. Epub 2005 Jan 31.

PMID:
15684317
9.

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.

Finazzi G, Caruso V, Marchioli R, Capnist G, Chisesi T, Finelli C, Gugliotta L, Landolfi R, Kutti J, Gisslinger H, Marilus R, Patrono C, Pogliani EM, Randi ML, Villegas A, Tognoni G, Barbui T; ECLAP Investigators.

Blood. 2005 Apr 1;105(7):2664-70. Epub 2004 Dec 7.

10.

Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.

Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C.

Leuk Lymphoma. 2004 Jun;45(6):1141-7.

PMID:
15359993
11.

A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.

Santini G, De Souza C, Aversa S, Patti C, Tedeschi L, Candela M, Olivieri A, Chisesi T, Rubagotti A, Centurioni R, Nardi V, Congiu M, Gennaro M, Truini M; Italian Non-Hodgkin's Lymphoma Co-operative Study Group.

Braz J Med Biol Res. 2004 May;37(5):719-28. Epub 2004 Apr 22.

12.

Do human myeloma cells directly produce basic FGF?

Colla S, Morandi F, Lazzaretti M, Polistena P, Svaldi M, Coser P, Bonomini S, Hojden M, Martella E, Chisesi T, Rizzoli V, Giuliani N.

Blood. 2003 Oct 15;102(8):3071-2; author reply 3072-3. No abstract available.

13.

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Ladetto M, Corradini P, Vallet S, Benedetti F, Vitolo U, Martelli M, Brugiatelli M, Coser P, Perrotti A, Majolino I, Fioritoni G, Morandi S, Musso M, Zambello R, Chisesi T, Di Renzo N, Vivaldi P, De Crescenzo A, Gallamini A, Salvi F, Santini G, Boccomini C, Sorio M, Astolfi M, Drandi D, Pileri A, Tarella C.

Blood. 2002 Sep 1;100(5):1559-65.

14.

ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.

Chisesi T, Federico M, Levis A, Deliliers GL, Gobbi PG, Santini G, Luminari S, Linfomi MB; Intergruppo Italiano Linfomi.

Ann Oncol. 2002;13 Suppl 1:102-6.

PMID:
12078888
15.

Risk of second cancer in patients with hairy cell leukemia: long-term follow-up.

Federico M, Zinzani PL, Frassoldati A, Vinceti M, Modè A, Annino L, Chisesi T, Pagnucco G, Invernizzi R, Spriano M, Resegotti L, Bendandi M, Damasio EE; Italian Cooperative Group for the Study of Hairy Cell Leukemia.

J Clin Oncol. 2002 Feb 1;20(3):638-46.

PMID:
11821443
16.

Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patients.

Chisesi T, Polistena P, Contu A, Coser P, Indrizzi L, Leoni P, Majolino I, Porcellini A, Salvagno L, Zambaldi G, Rizzoli V, Congiu AM, Santini G; Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).

Leuk Lymphoma. 2001 Mar;41(1-2):125-36.

PMID:
11342364
17.

Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.

Santini G, Nati S, Spriano M, Gallamini A, Pierluigi D, Congiu AM, Truini M, Rubagotti A, Chisesi T, Vimercati R, Rossi E, Sertoli MR, Mattei D, Marino G, Gobbi M.

Haematologica. 2001 Mar;86(3):282-6.

18.

VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.

Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.

Haematologica. 2000 Feb;85(2):160-6.

19.

Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.

Federico M, Vitolo U, Zinzani PL, Chisesi T, Clò V, Bellesi G, Magagnoli M, Liberati M, Boccomini C, Niscola P, Pavone V, Cuneo A, Santini G, Brugiatelli M, Baldini L, Rigacci L, Resegotti L.

Blood. 2000 Feb 1;95(3):783-9.

20.

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

Santini G, Salvagno L, Leoni P, Chisesi T, De Souza C, Sertoli MR, Rubagotti A, Congiu AM, Centurioni R, Olivieri A, Tedeschi L, Vespignani M, Nati S, Soracco M, Porcellini A, Contu A, Guarnaccia C, Pescosta N, Majolino I, Spriano M, Vimercati R, Rossi E, Zambaldi G, Mangoni L, Rizzoli V, et al.

J Clin Oncol. 1998 Aug;16(8):2796-802.

PMID:
9704732
21.

Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.

Santini G, Congiu AM, Nati S, Canepa L, Spriano M, Chisesi T, Rossi E, Vimercati R, Sertoli MR, Figari O, Gobbi M, Piaggio G, Vassallo F, Benvenuto F, Soracco M, Miglino M, Ravetti JL, Truini M.

Leuk Lymphoma. 1997 Dec;26 Suppl 1:83-8.

PMID:
9570684
22.

Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.

Santini G, Congiu AM, Nati S, Pierluigi D, Spriano M, Chisesi T, Rossi E, Vimercati R, Sertoli MR, Figari O, Gobbi M, Piaggio G, Vassallo F, Benvenuto F, Soracco M, Miglino M, Bruni R, Ravetti JL, Truini M.

Leukemia. 1996 Jun;10 Suppl 2:s88-91.

PMID:
8649061
23.

Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.

Federico M, Frassoldati A, Lamparelli T, Foà R, Brugiatelli M, Annino L, Baldini L, Capnist G, Chisesi T, di Celle PF, et al.

Ann Oncol. 1994 Oct;5(8):725-31.

PMID:
7826905
24.

Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).

Capnist G, Federico M, Chisesi T, Resegotti L, Lamparelli T, Fabris P, Rossi G, Invernizzi R, Guarnaccia C, Leoni P, et al.

Leuk Lymphoma. 1994 Aug;14(5-6):457-64.

PMID:
7812205
25.

MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

Sertoli MR, Santini G, Chisesi T, Congiu AM, Rubagotti A, Contu A, Salvagno L, Coser P, Porcellini A, Vespignani M, et al.

J Clin Oncol. 1994 Jul;12(7):1366-74.

PMID:
7517442
26.

Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.

Trentin L, Zambello R, Agostini C, Siviero F, Adami F, Marcolongo R, Raimondi R, Chisesi T, Pizzolo G, Semenzato G.

Blood. 1993 Feb 1;81(3):752-8.

28.

Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.

Zambello R, Trentin L, Bulian P, Cassatella M, Raimondi R, Chisesi T, Agostini C, Semenzato G.

Blood. 1992 Oct 15;80(8):2030-7.

29.

Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.

Zambello R, Cassatella MA, Trentin L, Bulian P, Siviero F, Feruglio C, Agostini C, Vespignani M, Chisesi T, Pizzolo G, et al.

Leukemia. 1991 Nov;5(11):942-50.

PMID:
1835747
30.

Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).

Santini G, Contu A, Porcellini A, Chisesi T, Coser P, Congiu AM, Morandi S, Manna A, Schintu GM, Quaini R, et al.

Haematologica. 1991 Nov-Dec;76(6):485-90.

PMID:
1820985
31.

Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes.

Pandolfi F, Foa R, De Rossi G, Zambello R, Chisesi T, di Celle PF, Migone N, Casorati G, Scarselli E, Ensoli F, et al.

Clin Immunol Immunopathol. 1991 Sep;60(3):371-83.

PMID:
1830831
32.

Splenic irradiation in chronic lymphocytic leukemia.

Chisesi T, Capnist G, Dal Fior S.

Eur J Haematol. 1991 Apr;46(4):202-4.

PMID:
2015875
33.

Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).

Santini G, Coser P, Chisesi T, Porcellini A, Sertoli R, Contu A, Vinante O, Congiu AM, Carella AM, D'Amico T, et al.

Ann Oncol. 1991 Feb;2 Suppl 2:181-5.

PMID:
2049316
34.

Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study. Non-Hodgkin's Lymphoma Cooperative Study Group.

Chisesi T, Congiu M, Contu A, Coser P, Moretti L, Porcellini A, Rancan L 6th, Salvagno L, Santini G, Vinante O.

Eur J Cancer. 1991;27 Suppl 4:S31-3.

PMID:
1799472
35.

Does the Therapy According to Stage Improve Response and Survival in Multiple Myeloma Patients?

Capnist G, Chisesi T.

Leuk Lymphoma. 1991;3(5-6):409-17. doi: 10.3109/10428199109070285.

PMID:
27467432
36.

Treatment of Early Stage Hodgkin's Disease According to Risk Factors.

Chisesi T, Vespignani M, Capnist G, Rancan L, Raimondi R, Fior SD, Stracca-Pansa V, Rodighiero G, Cappellari F, Dini E.

Leuk Lymphoma. 1991;4(2):137-43. doi: 10.3109/10428199109068057.

PMID:
27462944
37.

Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG.

Santini G, Congiu AM, Coser P, Chisesi T, Porcellini A, Sertoli R, Contu A, Vinante O, Pierluigi D, Vitale V, et al.

Leukemia. 1991;5 Suppl 1:42-5.

PMID:
1890865
38.

Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.

Capnist G, Federico M, Chisesi T, Resegotti L, Pagnucco G, Castoldi GL, Lamparelli T, Frassoldati A, Guarnaccia C, Leoni P, et al.

Leuk Res. 1991;15(6):419-26.

PMID:
1861528
39.

Tumor necrosis factor-alpha and B-cell growth factor induce leukemic hairy cells to proliferate in vitro.

Trentin L, Zambello R, Pizzolo G, Vinante F, Ambrosetti A, Chisesi T, Vespignani M, Feruglio C, Adami F, Agostini C, et al.

Cancer Detect Prev. 1991;15(5):385-90.

PMID:
1751949
40.

ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).

Chisesi T, Santini G, Capnist G, Coser P, Contu A, Porcellini A, Rizzoli V, Sertoli M, Rancan L, Salvagno L, et al.

Leukemia. 1991;5 Suppl 1:107-11.

PMID:
1716334
41.

Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.

Zambello R, Trentin L, Pizzolo G, Bulian P, Masciarelli M, Feruglio C, Agostini C, Raimondi R, Chisesi T, Semenzato G.

Blood. 1990 Nov 15;76(10):2080-5.

42.

Recurrent chromosomal aberrations in peripheral T-cell lymphoma.

Montaldi A, Chisesi T, Stracca-Pansa V, Celli P, Vespignani M, Stella M.

Cancer Genet Cytogenet. 1990 Aug 1;48(1):39-48.

PMID:
2372786
43.

[Therapy with alpha-interferon in non-Hodgkin's lymphoma with a low grade of malignancy (correct title supplied from Table of Contents)].

Chisesi T.

Haematologica. 1990 Jul-Aug;75 Suppl 4:72-7. Review. Italian. No abstract available.

PMID:
2074057
44.

[Hairy-cell leukemia as a model for studying the effects of interferon on the immune system].

Semenzato G, Trentin L, Bulian P, Agostini C, Chisesi T, Pizzolo G.

Haematologica. 1990 Jul-Aug;75 Suppl 4:10-9. Review. Italian. No abstract available.

PMID:
1705910
45.

Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.

Trentin L, Zambello R, Agostini C, Ambrosetti A, Chisesi T, Raimondi R, Bulian P, Pizzolo G, Semenzato G.

Blood. 1990 Apr 1;75(7):1525-30.

46.

Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study.

Pandolfi F, Loughran TP Jr, Starkebaum G, Chisesi T, Barbui T, Chan WC, Brouet JC, De Rossi G, McKenna RW, Salsano F, et al.

Cancer. 1990 Jan 15;65(2):341-8.

PMID:
2403836
47.

Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.

Damasio EE, Federico M, Frassoldati A, Lamparelli T, Annino L, Bernasconi C, Chisesi T, Foá R, Lauria F, Pagnucco G, et al.

Eur J Haematol Suppl. 1990;52:29-31.

PMID:
2279542
48.

Autologous bone marrow transplantation (ABMT) in poor prognosis diffuse non-Hodgkin's lymphomas (NHL). Report of Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).

Coser P, Santini G, Rizzoli V, Porcellini A, Chisesi T, Sertoli R, Contu A, Salvagno L, Vinante O, Rossi E, et al.

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:164. No abstract available.

PMID:
2697432
49.

Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes.

Zambello R, Pizzolo G, Trentin L, Agostini C, Chisesi T, Vinante F, Scarselli E, Zanotti R, Vespignani M, De Rossi G, et al.

Cancer. 1989 Nov 15;64(10):2019-23.

PMID:
2804889
50.

Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. A pilot study of the non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).

Santini G, Coser P, Chisesi T, Porcellini A, Sertoli R, Contu A, Congiu AM, Manna A, Rossi E, Scarpati D, et al.

Bone Marrow Transplant. 1989 Jul;4(4):399-404.

PMID:
2673460

Supplemental Content

Loading ...
Support Center